OBJECTIVE: There are presently a great number of publications pertaining to the clinical risk factors associated with @entity259 . These studies deal mostly with a single feature from either @entity1 demographics, physical examination, laboratory values, imaging, or cytology. We sought to create a novel scoring system that integrates the diagnostic indices of each of these clinical features for @entity189 . METHODS: A retrospective analysis of 1047 consecutive thyroidectomy @entity1 was performed. Each @entity1 was assigned a @entity5 risk score according to a newly devised 22-variable scoring scheme termed the McGill Thyroid Nodule Score (MTNS). The MTNS was developed by a multidisciplinary team of endocrinologists, thyroid surgeons, and pathologists using already established evidence-based risk factors for @entity259 . RESULTS: The exact incidence of @entity5 was calculated for each MTNS score based on final pathology. The incidence for scores of 1 to 3 was 27%, of 4 to 7 was 32%, of 8 was 39%, of 9 to 11 was 63%, of 12 to 13 was 88%, and of 14 to 18 was 93%. All (130 of 130) @entity1 with a score >=  19 had @entity189 . A score  <= 8 correlated with a 32% (115 of 357) risk of @entity259 , whereas a score > 8 implied an 86% (417 of 487) risk. CONCLUSION: Our data suggest that a combined scoring system, the MTNS, can serve as an accurate predictor of the risk for @entity259 in a specific thyroid nodule. This will help physicians better formulate management decisions accordingly.

McGill Thyroid Nodule Score (MTNS): "rating the risk," a novel predictive scheme for XXXX risk determination.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity259 :: ('MESH:D013964', 'Disease') :: ['thyroid cancer'] @entity189 :: ('MESH:D002277', 'Disease') :: ['carcinoma'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer', 'malignancy']
@entity5 :: (MESH:D009369,Disease) :: ['cancer']
